U.S. Markets closed

Behind Jazz’s Strategic Collaboration with ImmunoGen

Daniel Collins

In August 2017, Jazz Pharmaceuticals (JAZZ) and ImmunoGen (IMGN) entered into a strategic collaboration and option agreement.